Leo I Gordon

Leo I Gordon

Northwestern University - Evanston / United States
Others
AD Scientific Index ID: 852171
person_outline Leo I Gordon's MOST POPULAR ARTICLES
1-) Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design studyJS Abramson, ML Palomba, LI Gordon, MA Lunning, M Wang, J Arnason, ...The Lancet 396 (10254), 839-852, 202016352020
2-) Randomized controlled trial of yttrium-90–labeled ibritumomab tiuxetan radioimmunotherapy versus rituximab immunotherapy for patients with relapsed or refractory low-grade …TE Witzig, LI Gordon, F Cabanillas, MS Czuczman, C Emmanouilides, ...Journal of clinical oncology 20 (10), 2453-2463, 200215872002
3-) Treatment of patients with low-grade B-cell lymphoma with the combination of chimeric anti-CD20 monoclonal antibody and CHOP chemotherapyMS Czuczman, AJ Grillo-Lopez, CA White, M Saleh, L Gordon, ...Journal of Clinical Oncology 17 (1), 268-268, 199912011999
4-) Axicabtagene ciloleucel as second-line therapy for large B-cell lymphomaFL Locke, DB Miklos, CA Jacobson, MA Perales, MJ Kersten, OO Oluwole, ...New England Journal of Medicine 386 (7), 640-654, 202210942022
5-) Genetic and functional drivers of diffuse large B cell lymphomaA Reddy, J Zhang, NS Davis, AB Moffitt, CL Love, A Waldrop, S Leppa, ...Cell 171 (2), 481-494. e15, 201710802017